tradingkey.logo
tradingkey.logo
Search

ImageneBio Ord Shs

IMA
Add to Watchlist
5.590USD
+0.020+0.36%
Close 07-24 16:00ETQuotes delayed by 15 min
63.05MMarket Cap
LossP/E TTM

More Details of Company

ImageneBio Ord Shs Info

Ticker Symbol- -
Company name- -
IPO date- -
CEO- -
Number of employees- -
Security type- -
Fiscal year-end- -
Address- -
City- -
Stock exchange- -
Country- -
Postal code- -
Phone- -
Website- -
Ticker Symbol- -
IPO date- -
CEO- -

Company Executives of ImageneBio Ord Shs

Name
Name/Position
Position
Shareholding
Change
Dr. Kristin Yarema, Ph.D.
Dr. Kristin Yarema, Ph.D.
Chief Executive Officer, Interim Principal Financial Officer, Director
Chief Executive Officer, Interim Principal Financial Officer, Director
85.40K
--
Ms. Erin Butler
Ms. Erin Butler
Senior Vice President - Finance, Administration
Senior Vice President - Finance, Administration
25.55K
+88.06%
Mr. Joseph P. Slattery
Mr. Joseph P. Slattery
Director
Director
16.00K
--
Dr. Yufang Lu, M.D., Ph.D.
Dr. Yufang Lu, M.D., Ph.D.
Chief Medical Officer
Chief Medical Officer
--
--
Name
Name/Position
Position
Shareholding
Change
Dr. Kristin Yarema, Ph.D.
Dr. Kristin Yarema, Ph.D.
Chief Executive Officer, Interim Principal Financial Officer, Director
Chief Executive Officer, Interim Principal Financial Officer, Director
85.40K
--
Ms. Erin Butler
Ms. Erin Butler
Senior Vice President - Finance, Administration
Senior Vice President - Finance, Administration
25.55K
+88.06%
Mr. Joseph P. Slattery
Mr. Joseph P. Slattery
Director
Director
16.00K
--
Dr. Yufang Lu, M.D., Ph.D.
Dr. Yufang Lu, M.D., Ph.D.
Chief Medical Officer
Chief Medical Officer
--
--

FAQs

Who are the top five shareholders of ImageneBio Ord Shs?

The top five shareholders of ImageneBio Ord Shs are: Dr. Kristin Yarema, Ph.D.
tradingkey.logo
Risk Warning: Our Website and Mobile App provides only general information on certain investment products. Finsights does not provide, and the provision of such information must not be construed as Finsights providing, financial advice or recommendation for any investment product.
Investment products are subject to significant investment risks, including the possible loss of the principal amount invested and may not be suitable for everyone. Past performance of investment products is not indicative of their future performance.
Finsights may allow third party advertisers or affiliates to place or deliver advertisements on our Website or Mobile App or any part thereof and may be compensated by them based on your interaction with the advertisements.
© Copyright: FINSIGHTS MEDIA PTE. LTD. All Rights Reserved.